2192.HK · MEDLIVE
Hong Kong · RS rating 21 · As of 2026-10-14
| Price | 6.57 HKD |
|---|---|
| 1-day change | -0.3% |
| RS rating (overall / 1M / 3M / 12M) | 21 / 41 / 24 / 22 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 24 / 15 / 18 |
| Industry group (rank) | Other Healthcare (20) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | – |
| Distance from 52-week high | +52.4% |
| Market cap (USD) | $621.5M |